Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.200
-0.020 (-0.91%)
Sep 15, 2026, 1:45 PM EDT - Market open
Lipocine Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.57 | 1.98 | 11.2 | -2.85 | 0.5 | 16.14 | |
Revenue Growth | -62.70% | -82.35% | - | - | -96.90% | - |
Gross Profit | 1.57 | 1.98 | 11.2 | -2.85 | 0.5 | 16.14 |
Selling, General & Admin | 3.95 | 3.76 | 5 | 4.9 | 4.06 | 5.33 |
Research & Development | 10.19 | 8.58 | 7.35 | 10.18 | 8.56 | 7.67 |
Operating Expenses | 14.14 | 12.35 | 12.35 | 15.08 | 12.62 | 13 |
Operating Income | -12.57 | -10.37 | -1.16 | -17.93 | -12.12 | 3.15 |
Interest Expense | - | - | - | - | -0.03 | -0.2 |
Interest & Investment Income | 0.72 | 0.74 | 1.15 | 1.37 | 0.57 | 0.07 |
Other Non Operating Income (Expenses) | - | - | 0.02 | 0.21 | 0.57 | 0.36 |
EBT Excluding Unusual Items | -11.85 | -9.63 | 0.01 | -16.35 | -11.01 | 3.37 |
Legal Settlements | - | - | - | - | 0.25 | -4 |
Pretax Income | -11.85 | -9.63 | 0.01 | -16.35 | -10.76 | -0.63 |
Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 |
Net Income | -11.85 | -9.63 | 0.01 | -16.35 | -10.76 | -0.63 |
Preferred Dividends & Other Adjustments | - | - | - | 0 | - | - |
Net Income to Common | -11.85 | -9.63 | 0.01 | -16.35 | -10.76 | -0.63 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 7 | 5 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 7 | 5 | 5 | 5 | 5 | 5 |
Shares Change | 22.05% | 0.48% | 2.90% | 0.26% | 1.98% | 57.35% |
EPS (Basic) | -1.82 | -1.77 | 0.00 | -3.10 | -2.06 | -0.12 |
EPS (Diluted) | -1.82 | -1.77 | -0.00 | -3.14 | -2.15 | -0.19 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -11.19 | -9.76 | -1.31 | -11.88 | -12.1 | -4.42 |
Free Cash Flow Per Share | -1.71 | -1.79 | -0.24 | -2.25 | -2.30 | -0.86 |
Gross Margin | 100.00% | 100.00% | 100.00% | - | 100.00% | 100.00% |
Operating Margin | -800.82% | -524.69% | -10.32% | - | -2423.88% | 19.49% |
Profit Margin | -755.13% | -487.05% | 0.07% | - | -2151.73% | -3.93% |
Free Cash Flow Margin | -713.03% | -493.79% | -11.71% | - | -2420.53% | -27.38% |
EBITDA | -12.51 | -10.31 | -1.11 | -17.9 | -12.11 | 3.15 |
EBITDA Margin | - | - | -9.95% | - | - | 19.49% |
D&A For EBITDA | 0.06 | 0.06 | 0.04 | 0.03 | 0.01 | 0 |
EBIT | -12.57 | -10.37 | -1.16 | -17.93 | -12.12 | 3.15 |
EBIT Margin | - | - | -10.31% | - | - | 19.49% |
Effective Tax Rate | - | - | 7.54% | - | - | - |
Revenue as Reported | 1.57 | 1.98 | 11.2 | -2.85 | 0.5 | - |